ADVERTISEMENT

How best to approach these acute hand infections

The Journal of Family Practice. 2020 January;69(1):E1-E8
Author and Disclosure Information

Antimicrobial therapy is not straightforward with the 4 infectious conditions reviewed here. Combination therapy at the start must usually be tailored once an organism is known.

PRACTICE RECOMMENDATIONS

› Obtain a sample of pus for Gram stain and for ­cultures of aerobic and ­anaerobic organisms, ­acid-fast ­bacilli, and fungi. A

› Use antibiotics as an ­adjunct to ­elevation and splinting in flexor ­tenosynovitis to ­improve range-of-motion outcomes. A

› Notify your ­microbiology lab to enrich cultures with 10% CO2 to isolate Eikenella corrodens. A

› Consider ­prescribing ­acyclovir, f­amciclovir, or valacyclovir for ­herpetic whitlow. B

Strength of recommendation (SOR)

A Good-quality patient-oriented evidence
B Inconsistent or limited-quality patient-oriented evidence
C Consensus, usual practice, opinion, disease-oriented evidence, case series

Antimicrobial therapy is not easy. No single regimen covers all possibilities. Start antimicrobial treatment empirically with wide-spectrum coverage, and tailor the regimen, as needed, based on microbiology ­results.

In clean surgical procedures, S aureus is the most common pathogen. It is acceptable to start empirical treatment with an antistaphylococcal penicillin, first-generation cephalosporin, or clindamycin. In contaminated wounds, gram-negative bacteria, anaerobes, fungal organisms, and mixed infections are more commonly seen.35-37

Felon has occurred in individuals with diabetes, who regularly check their blood-sugar level.

First-generation cephalosporin provides good coverage for gram-positive and gram-negative bacteria in clean wounds. However, in contaminated wounds with devitalized tissue, a more aggressive scheme is recommended: start with a penicillin and aminoglycoside.35-37 In some cases, monotherapy with either ampicillin/sulbactam, imipenem, meropenem, piperacillin/tazobactam, or tigecylline may be sufficient until culture results are available; at that point, antibiotic coverage can be narrowed as indicated (TABLE 27).35,36

Recommended dosages for commonly used antibiotics

CORRESPONDENCE
Carlos A. Arango, MD, 8399 Bayberry Road, Jacksonville, FL 32256; carlos.arango@jax.ufl.edu.